Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 Clinical research trials and A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3. A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 clinical trial. Participants oftentimes recieve the finest healthcare available for their A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3



A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

For Condition: HIV Infections
Status: Completed
Sponsor(s): Gilead Sciences ,
Synopsis: To evaluate the anti-HIV activity, safety, and tolerance of adefovir dipivoxil ( bis-POM PMEA ) in combination with standard antiretroviral therapy for 48 weeks.
Details: Patients are randomized to receive either adefovir dipivoxil or placebo daily for 24 weeks, after which all patients will receive open-label drug for an additional 24 weeks. Study drug is administered in combination with a current antiretroviral regimen for the entire 48 weeks. Patients are followed every 4 weeks during the first 24 weeks of study, then every 8 weeks during the last 24 weeks.
Eligibility:
Study Type:
  Interventional, Treatment, Double-Blind, Safety Study
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV infection with HIV RNA titer >= 2500 copies/ml (2.5 KEq/ml) plasma. - CD4 count >= 200 cells/mm3. - No new AIDS-defining event within the past 2 months. - Life expectancy at least 1 year. - Consent of parent or guardian if less than 18 years old. - Tolerated antiretroviral therapy for the past 2 months. NOTE: - Kaposi's sarcoma is permitted provided patient has not received systemic therapy within the past month. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Active, serious infections other than HIV that require parenteral antibiotic or antiviral therapy. - Gastrointestinal malabsorption syndrome or chronic nausea or vomiting that would preclude oral medication. - Malignancy other than Kaposi's sarcoma or basal cell carcinoma. Concurrent Medication: Excluded: - Immunomodulating agents such as systemic corticosteroids, IL-2, or interferons. - Isoniazid. - Rifampin. - Investigational agents (unless approved by sponsor). - Systemic chemotherapeutic agents. Prior Medication: Excluded: - Parenteral antibiotic or antiviral therapy for another active, serious infection within the past 2 weeks. - Immunomodulating agents such as systemic corticosteroids, IL-2, or interferons within the past month. - Systemic therapy for KS within the past month. Required: - Antiretroviral regimen other than study drug. Required: - Antiretroviral therapy for at least the past 2 months. Current alcohol or substance abuse that would interfere with compliance.
Total Enrollment: 400

Location and Contact Information:

Univ of South Florida
St. Petersburg,  Florida,  33705
United States
 

Univ of Wisconsin
Madison,  Wisconsin,  53792
United States
 

Wayne State Univ / Univ Health Ctr
Detroit,  Michigan,  48201
United States
 

Saint Vincent's Med Ctr
New York City,  New York,  10011
United States
 

San Mateo County Med Ctr / San Mateo County AIDS Prog
San Mateo,  California,  94403
United States
 

The Research and Education Group
Portland,  Oregon,  97210
United States
 

Carolinas Med Ctr
Charlotte,  North Carolina,  28204
United States
 

East Bay AIDS Ctr
Berkeley,  California,  94705
United States
 

Chicago Ctr for Clinical Research
Chicago,  Illinois,  60610
United States
 

Houston Clinical Research Network
Houston,  Texas,  77004
United States
 

Tulane Univ / Tulane / LSU Clinical Trials Unit
New Orleans,  Louisiana,  70122
United States
 

San Francisco Gen Hosp
San Francisco,  California,  94115
United States
 

Harvard Univ / Massachusetts Gen Hosp
Boston,  Massachusetts,  02114
United States
 

AIDS Research Consortium of Atlanta
Atlanta,  Georgia,  303081962
United States
 

Dallas VA Med Ctr
Dallas,  Texas,  75216
United States
 

Santa Clara Valley Med Ctr
San Jose,  California,  951282699
United States
 

Vanderbilt Univ Med Ctr
Nashville,  Tennessee,  37212
United States
 

Institute for Clinical Research
Washington D.C.,  District of Columbia,  20422
United States
 

Univ of Utah School of Medicine
Salt Lake City,  Utah,  84132
United States
 

Northwestern Univ Med Ctr
Chicago,  Illinois,  60611
United States
 

Univ of Texas
Galveston,  Texas,  77555
United States
 

Albany Med College / Clinical Pharmacy Studies
Albany,  New York,  12208
United States
 

Georgetown Univ Med Ctr
Washington D.C.,  District of Columbia,  20007
United States
 

Harbor UCLA Med Ctr
Torrance,  California,  90502
United States
 

Univ of Alabama at Birmingham
Birmingham,  Alabama,  35294
United States
 

Kraus Med Partners
Los Angeles,  California,  90509
United States
 

Pacific Oaks Research
Sherman Oaks,  California,  91403
United States
 

Saint Vincent's Med Ctr
New York City,  New York,  10011
United States
 


Additional Information:
Study ID Numbers:
  232C;  GS-96-408
Study Start Date: 
Record last reviewed: May 1997
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002161

Other Hiv Infections Studies:
1. The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

2. When to Start Anti-HIV Drugs in Patients with Opportunistic Infections

3. The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

4. Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients

5. Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination with Nelfinavir in HIV-Positive Children

Related Studies:

Other HIV Infections Clinical Trials
Other Tennessee Clinical Trials
Other Nashville Clinical Trials

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

Modify your Search

  Other HIV Infections Clinical Trials
  Other Tennessee Clinical Trials
  Other Nashville Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103